Anteris Technologies Global Corp. Common Stock
AVR
$5.60−3.11%
At close · Nov 3, 2026
Mkt cap
$287.16M
EV/Sales
146.6
P/E ratio
—
FY2025 Revenue
$1.91M
EPS (TTM)
−$2.66
Gross Margin (FY2025)
70.26%
Profit Margin (FY2025)
−4921.28%
Beta
0.74
Div yield
—
Sector
Healthcare
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Latest
AVR earnings
Analysts
RatingsSector-relative grades for valuation, growth, profitability, momentum and revisions
Form 4 trades, last 90 days
Latest SEC filings
Source: SEC EDGAR · Latest filing Sep 23, 2026
Latest stored headlines
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
Latest reported AVR revenue for 2025-12-31 was $1.9M. Net income was -$94.1M. Revenue was down 29.2% from 2024-12-31 to 2025-12-31. AVR currently screens at market cap $287.2M.
Use this AVR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AVR income, balance, and cash tables.
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company in the Healthcare sector.
Latest cached Anteris Technologies Global Corp. Common Stock (AVR) revenue for Dec 31, 2025 was $1.9M. Net income was -$94.1M. Statements: https://lician.com/financials/avr
Anteris Technologies Global Corp. Common Stock (AVR) market capitalization is $287.2M on the latest cached snapshot.
Anteris Technologies Global Corp. Common Stock (AVR) cached previous close $5.78; day range $5.58 – $5.88; volume 1,169,069. Session quote: https://lician.com/quote/avr
Anteris Technologies Global Corp. Common Stock (AVR) latest cached earnings event is "AVR earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AVR filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/avr
SEC filings · latest fiscal year FY2025
−29.2%
Revenue growth year over year
10-Q results and the earnings calendar
Revenue and EPS are GAAP diluted from the 10-Q. Beat or miss compares the calendar's actual with its estimate on the same basis (adj.), or revenue with the revenue estimate.
Institutional holders from SEC 13F filings
Quant rating
MetricsHow it works1.36Strong Sell
Lician Quant Grades · vs 548 Healthcare stocks · Nov 4, 2026
Next earnings
Wed, Nov 11Estimated
Time not announced · in 7 days
EPS est. — · 4 est.
Earnings
Short interest
46.3%of float
5.0 days to cover
+18.9% vs prior report
FINRA · settled Oct 15Short data
52-week range
$3.38$10.57
Price $5.60 · 47.0% below high
Low $3.38, high $10.57, last $5.60.Daily closesChart
Get alerted when AVR confirms or moves its Nov 11 report
Free account, no card. Earnings date alerts are free for every stock on your watchlist; beat/miss results come with Pro.